Overview publication
Title | Renal Impairment, Cardiovascular Disease, and the Short-Term Efficacy and Safety of PCSK9 Targeted by Inclisiran. |
Date | January 1st, 2020 |
Issue name | Mayo Clinic proceedings |
Issue number | v95.1:12-14 |
DOI | 10.1016/j.mayocp.2019.11.010 |
Authors | |
Read | Read publication |